Hormone therapy shouldn’t feel like a battle with your own body. Yet today:
We don't accept that as the status quo.
Maman Biomedical develops microneedle platforms for drug delivery.
A single-use microneedle device that replaces the traditional needle for hormone injections. Port delivers the same prescribed fertility medications — but without the pain and trauma of a hypodermic needle.
A dissolving microneedle patch designed to deliver fertility hormones painlessly and over time. Patch combines drug loading with sustained release, eliminating daily injections and reducing hormonal loading — making fertility treatment simpler, safer, and needle-free.
A wearable biosensor and companion app that tracks hormone utilization in real time through the skin. Sense accompanies Port and Patch to eliminate the need for blood draws during treatment, offering seamless, non-invasive monitoring to improve treatment precision and patient confidence.
Latchmi Raghunanan
PhD in Materials Science with 13+ years of expertise in soft matter chemistry and medtech innovation. Former R&D, SRED & IP lead at an early-stage medtech startup; 5 granted patents, 15 peer-reviewed publications.
Roopchand Raghunanan
Executive leader with 20+ years in organizational development and program management. Directed budgets of $248M. Recognized for transformational leadership in strategy and change management.
